S HANALL BIOPHARMA [Decision on Disposal of Treasury Stock]
☞ This disclosure is under the jurisdiction of [Korea Exchange’s Securities Market Headquarters]. ☞ This document is not the official English version of the legal disclosure as stipulated under the Financial Investment Services & Capital Markets Act(§161) or the Enforcement Decree of the Financial Investment Services & Capital Markets Act(§171). As such, the FSS is not responsible for the contents of the following disclosure. This document was disclosed voluntarily by the relevant party according to the KRX's disclosure rule. The original Korean version of the disclosure can be found on KIND (http://engkind.krx.co.kr). If and when there is any discrepancy between the English and Korean versions, the Korean text shall prevail.